Danco Laboratories and GenBioPro asked the Supreme Court to restore mail-order access to mifepristone on Saturday. - The request comes one day after an appeals court temporarily blocked mail deliveries. - It's the latest front in a series of legal battles since the Supreme Court overturned Roe v. WASHINGTON — Two drugmakers have asked the Supreme Court to restore mail-order access to mifepristone, a move that would continue to allow women access to one of the most widely used abortion methods pending ongoing legal challenges.
Latest development
Media Coverage · May 3, 2026
The court issued an order.
newspaper Read articleDanco Laboratories and GenBioPro asked the Supreme Court to restore mail-order access to mifepristone on Saturday. - The request comes one day after an appeals court temporarily blocked mail deliveries. - It's the latest front in a series of legal battles since the Supreme Court overturned Roe v. WASHINGTON — Two drugmakers have asked the Supreme Court to restore mail-order access to mifepristone, a move that would continue to allow women access to one of the most widely used abortion methods pe
Open original open_in_newBy Ismail Shakil May 2 (Reuters) – Two drugmakers have asked the U.S. Supreme Court to restore mail-order access to mifepristone, a move that would continue to allow women access to one of the most widely used abortion methods pending ongoing legal challenges. Danco Laboratories and GenBioPro both filed applications with the top court on Saturday, one day after an appeals court temporarily blocked deliveries, significantly curtailing access to the drug nationwide and particularly in states that
Open original open_in_newJuryvine summaries are generated from court records. Expand "Source" on any row to see the underlying filing.
The court issued an order.
The court issued an order.
Danco Laboratories and GenBioPro asked the Supreme Court to restore mail-order access to mifepristone on Saturday. - The request comes one day after an appeals court temporarily blocked mail deliveries. …
By Ismail Shakil May 2 (Reuters) – Two drugmakers have asked the U.S. Supreme Court to restore mail-order access to mifepristone, a move that would continue to allow women access …
By Ismail Shakil May 2 (Reuters) – Two drugmakers have asked the U.S. Supreme Court to restore mail-order access to mifepristone, a move that would continue to allow women access …
Sources tracked
3 outlets · 3 articles
Timeline events
2 records on file
Last updated
2 hours, 23 minutes ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.